Marc Carrier/LinkedIn;Caterina E. Marx
/researchgate.net
Apr 17, 2026, 12:44
Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Managing recurrent VTE despite anticoagulation in patients with cancer remains one of the most challenging scenarios in thrombosis care.
This ‘How I Treat’ review outlines a pragmatic potential approach:
- Confirm true recurrence (versus residual clot)
- Assess adherence, drug interactions, and absorption
- Optimize anticoagulation (LMWH escalation or switch)
Despite these strategies, recurrence and bleeding risks remain substantial highlighting the urgent need for more high-quality data.”
Title: How I treat breakthrough thrombosis in patients with cancer
Authors: Caterina E. Marx, Marc Carrier
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia